T2 BIOSYSTEMS INC - COM (TTOO)

CUSIP: 89853L104

Q4 2018 13F Holders as of 31 Dec 2018

Type / Class
Equity / COM
Total 13F shares
21,938,282
Share change
-2,282,797
Total reported value
$66,034,109
Put/Call ratio
110%
Price per share
$3.01
Number of holders
91
Value change
-$11,263,105
Number of buys
45
Number of sells
35

Quarterly Holders Quick Answers

What is CUSIP 89853L104?
CUSIP 89853L104 identifies TTOO - T2 BIOSYSTEMS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of T2 BIOSYSTEMS INC - COM (TTOO) as of Q4 2018

As of 31 Dec 2018, T2 BIOSYSTEMS INC - COM (TTOO) was held by 91 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 21,938,282 shares. The largest 10 holders included GOLDMAN SACHS GROUP INC, Senvest Management, LLC, BlackRock Inc., Polaris Venture Management Co. V, L.L.C., MORGAN STANLEY, TIGER MANAGEMENT L.L.C., Vanguard Group Inc, ARDSLEY ADVISORY PARTNERS LP, Allianz Asset Management GmbH, and STATE STREET CORP. This page lists 91 institutional shareholders reporting positions in this security for the Q4 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.